Approval for Schering-Plough drug

Published: 3-Feb-1999


European pharmaceuticals regulators have approved Schering-Plough's new allergy drug, desloratadine, for hay fever treatment. The compound is a derivative of the active ingredient of the company's best-selling drug Clarityn, whose US patent expires next year, and will be sold under the brand names Aerius and Neoclarityn. The company is still awaiting FDA approval for the drug.

You may also like